Panacea Biotec Ltd Company History

Appoints Mr Rajesh Jain and Mr Sandeep Jain as the Joint Managing Directors of the company.

Files for worldwide patent for its new NDDS for an anti-TB combination drug.

Board approves for the subdivision of shares from Rs.10 per share of Re.1 per share , and also decides to wind up the company's wholly owned subsidiary at Isle of Man, UK.

Company's non-executive director makes a gift of 2,01,000 shares of Re.1 each representing 0.35% of the company's total capital.

Commences marketing of herbal and dietary supplement products under its SBU viz. "Best on Health" and launches ThankGod capsules, ThankGod Anytime cream, ThankGod pain & Itch relief cream etc.

Stock split from Rs 10 per equity share to Rs 1 per equity share

Panacea Biotec forays OTC market with Herbal Products

California-based Chiron Vaccines, the world's 5th largest vaccine producer, has struck a deal with Delhi-based Panacea Biotec to set up a joint venture in India

Panacea Biotec launches new product HEARTFELT, natural therapy for cholesterol management developed by its Research & Development Team.

Panacea rolls out new nimesulide injection

Launches Combination vaccines through JV with Chiron Vaccines, UK on November 24, 2004

Panacea Biotec launches 'Upright' for effective relief from severe pain & inflammation

Panacea Biotec introduces Noval Anti-allergy Drug - Ralif

Panacea Biotec enters into an agreement with PT Bio Farma to manufacture Measles Vaccine

Panacea Biotec signs agreement with Family Vaccines to supply combination vaccines

Panacea Biotec - EasyFive Injects; USD 222.37 million Award by UNICEF

Panacea Biotech's Baddi unit gets US FDA approval

Panacea Bio - Board recommends Dividend of Re. 0.25 (25%) each on Equity Shares of the Company, for the financial year 2009-10.

PanaceBiotec - Panacea Biotec Launches - PacliALL

Panacea Biotec announced that the company is mulling to foray into healthcare infrastructure sector with setting up of multi specialty hospital in Gurgaon, Haryana.

PanaceBiotec - Panacea Biotec celebrates 63rd Indian Republic day with launch of "POLPROTEC" in Nigeria".

Panacea Biotech launches Inactivated Polio Virus vaccine in Nigeria

PanaceBiotec - Panacea Biotec inaugurates state of the art Oncology Production Unit

PanaceBiotec - Panacea Biotec Entered into Strategic Alliance with Osmotica Pharmaceutical

Panacea Biotec wins order worth Rs 187 cr from Govt to supply polio vaccines

Panacea Biotec Ltd has opened up its wholly owned subsidiary in UAE in the name of Panol Industries.

Panacea Biotec Ltd has entered into collaboration with a leading International Pharmaceutical Company for the development and supply of an immunosuppressant generic product in USA.

"Panacea Biotec Announces Collaboration with Rising Pharmaceuticals Inc.".

Company has received UNICEF Award for supply of Companys DTB-HebB-Hib (Pentavalent) Vaccine Easyfive-TT to UNICEF.

Panacea Biotec Gets Pan American Health Organization (PAHO) order for supply of EasyFive-TT Vaccines worth

"Panacea Biotec Launches - CABAPAN, A Cost Effective product for the treatment of metastatic Castration Resistant Prostrate Cancer (mCRPC)".

Panacea Biotec Receives Prestigious Intellectual Property & Science Award "Top 50 Indian Innovators 2015"".

Panacea Biotec Launches - TENEPAN, a cost effective product for the treatment of Type 2 Diabetes Mellitus (T2DM)".

"Panacea Biotec Introduces World's First Fully Liquid Tetravalent Vaccine Easyfour-TT against DTP and Hib".

Panacea Biotec Introduces World's First Fully Liquid Hexavalent Combination Vaccine EasySixTM for Six Preventable Diseases.

Panacea Biotec announces ANDA approval for US Market and LTA & Award from UN Agencies for Supply of Pentavalent Vaccine (Easyfive-TT).

Panacea Biotec Announces Joint Collaboration with Bionpharma Inc.

Panacea Biotec inks Tripartite Agreement with Natco Pharma Ltd. and Breckenridge Pharmaceutical Inc. for manufacturing and supply of Azacitidine injection in the U.S. Market.

Panacea Biotec Announces Launch Of ViLACT For Treatment Of Uncontrolled Type 2 Diabetes Mellitus Patients.

Panacea Biotec receives USD 24.32 Million Award of Pentavalent Vaccine from U.N. Agencies.

RDIF and Panacea Biotec launch the production of Sputnik V in India.

Panacea Biotec supplies 1st shipment of the second component of Sputnik V vaccine produced in India.

Panacea Biotec receives UNICEF & PAHO awards for supply of Pentavalent Vaccine..

CEPI, THSTI and Panacea Biotec partner to develop broadly protective Betacoronavirus vaccines.

Panacea Biotec launches EasyFourPol in India and receives registration of Valganciclovir Powder for Oral Solution in Germany.

Panacea Biotec Launches Paclitaxel Protein-Bound Particles for Injectable Suspension (Albumin-Bound), a genericversion of Abraxane.

Launch of new range of high-quality pediatric food & nutritional products in India by Company's wholly owned subsidiary, Panacea Biotec Pharma Limited ''.